[
  {
    "0": {
      "company_name": "NEOPHARM",
      "document_title": "The Global Leader In Skin Science",
      "subtitle": null,
      "year": "2024",
      "korean_subtitle": "피부 과학의 선도기업"
    }
  },
  {
    "1": {
      "company_name": "NEOPHARM (네오팜)",
      "tagline": "The Global Leader In Skin Science (피부 과학의 선도기업)",
      "company_description": "네오팜은 피부과학의 선도기업으로서, 끊임없는 기술혁신으로 인류공헌에 앞장섭니다.",
      "summary_title": "Earnings Summary",
      "summary_sections": [
        "매출 및 손익 현황",
        "주요 채널별 매출 현황",
        "주요 제품군 매출 현황"
      ],
      "product_line_name": "ATOPALM",
      "products": [
        {
          "name": "TOP TO TOE WASH",
          "korean_name": "팝투토 워시",
          "description": "MoisturisingShampco&BodyWash",
          "features": [
            "세정 후에도 촉촉한 샘푸 경용 바스",
            "MLE (Multi-Lamellar Emulsion)"
          ]
        },
        {
          "name": "FACIAL FOAMWASH",
          "korean_name": "「OAMWASH",
          "description": "",
          "features": []
        },
        {
          "name": "MLE LOTION",
          "korean_name": "MLE 로션",
          "description": "Moisturising Emulsion",
          "features": [
            "MLE Skin Barrier Lotion",
            "수분 보증단 기능성 료선"
          ]
        },
        {
          "name": "PANTHENOL CREAM",
          "korean_name": "판테놀 크림",
          "description": "Internative Deep-Hydration Calming Cream",
          "features": [
            "집중 고보습 진정 크림"
          ]
        },
        {
          "name": "MLE CREAM",
          "korean_name": "엠엘이 크림",
          "description": "MLE Skin Barrier Cream",
          "features": [
            "기능성 화장품",
            "MLE 피부보호막 기능성 크림"
          ]
        },
        {
          "name": "PANTHENOL STICK BALM",
          "korean_name": "판테놀 스틱 밤",
          "description": "Calming Stick Balm ForSensitiveAreas",
          "features": [
            "현장 부유 진정 스틱 빔"
          ]
        }
      ]
    }
  },
  {
    "2": {
      "year": 2024,
      "quarter": "2분기",
      "earnings_summary": {
        "revenue": {
          "value": 306,
          "unit": "억원",
          "yoy_change_rate": 25.0,
          "notes": "비중국 중심 수출 성장 지속",
          "previous_year_quarter_value": 24498,
          "current_year_quarter_value": 30621
        },
        "operating_profit": {
          "value": 61,
          "unit": "억원",
          "yoy_change_rate": -2.7,
          "notes": "매출 믹스에 따른 원가 상승 영향",
          "previous_year_quarter_value": 6273,
          "current_year_quarter_value": 6107
        },
        "net_profit": {
          "value": 58,
          "unit": "억원",
          "yoy_change_rate": 7.6,
          "notes": "외화환산이익 증가 영향",
          "previous_year_quarter_value": 5469,
          "current_year_quarter_value": 5883
        }
      }
    }
  },
  {
    "3": {
      "company_name": "NEOPHARM",
      "report_details": {
        "title": "2024년 2분기 경영성과",
        "subtitle": "주요 채널별 매출 현황 (별도)"
      },
      "q2_2024_channel_performance": {
        "Online": {
          "major_channels": [
            "외부몰",
            "자사몰"
          ],
          "sales_amount_krw_billion": "88",
          "sales_ratio_percent": "29",
          "yoy_growth_status": "역성장"
        },
        "Offline": {
          "major_channels": [
            "병의원",
            "H&B"
          ],
          "sales_amount_krw_billion": "174",
          "sales_ratio_percent": "57",
          "yoy_growth_percent": "53"
        },
        "Export": {
          "major_regions": [
            "미주",
            "아시아",
            "중국",
            "기타"
          ],
          "sales_amount_krw_billion": "44",
          "sales_ratio_percent": "14",
          "regional_breakdown_krw_billion": {
            "Americas": "8.7",
            "Asia": "22",
            "China": "1.1",
            "Others": "12.3"
          },
          "yoy_growth_percent": "22"
        }
      },
      "channel_sales_trend_million_krw": {
        "unit": "백만원",
        "data": [
          {
            "quarter": "2023 2Q",
            "Online": "3609",
            "Offline": "11388",
            "Export": "9449"
          },
          {
            "quarter": "2023 3Q",
            "Online": "3676",
            "Offline": "10941",
            "Export": "7213"
          },
          {
            "quarter": "2023 4Q",
            "Online": "3669",
            "Offline": "15339",
            "Export": "8220"
          },
          {
            "quarter": "2024 1Q",
            "Online": "3878",
            "Offline": "16500",
            "Export": "7849"
          },
          {
            "quarter": "2024 2Q",
            "Online": "4419",
            "Offline": "17412",
            "Export": "8850"
          }
        ]
      }
    }
  },
  {
    "4": {
      "report_quarter": "2024 2분기",
      "product_categories": [
        {
          "category_name": "Skin Care",
          "main_brands": [
            "아토팜",
            "제로이드"
          ],
          "q2_2024_sales_amount": "173억",
          "q2_2024_sales_percentage": "57%",
          "yoy_growth": "6% 성장",
          "quarterly_sales_trend": [
            {
              "quarter": "2023 2Q",
              "sales_amount_in_million_krw": 903
            },
            {
              "quarter": "2023 3Q",
              "sales_amount_in_million_krw": 1400
            },
            {
              "quarter": "2023 4Q",
              "sales_amount_in_million_krw": 2084
            },
            {
              "quarter": "2024 1Q",
              "sales_amount_in_million_krw": 3395
            },
            {
              "quarter": "2024 2Q",
              "sales_amount_in_million_krw": 5125
            }
          ]
        },
        {
          "category_name": "Facial Care",
          "main_brands": [
            "리얼베리어",
            "티엘스"
          ],
          "q2_2024_sales_amount": "33억",
          "q2_2024_sales_percentage": "11%",
          "yoy_growth": "역성장",
          "quarterly_sales_trend": [
            {
              "quarter": "2023 2Q",
              "sales_amount_in_million_krw": 3498
            },
            {
              "quarter": "2023 3Q",
              "sales_amount_in_million_krw": 3649
            },
            {
              "quarter": "2023 4Q",
              "sales_amount_in_million_krw": 5095
            },
            {
              "quarter": "2024 1Q",
              "sales_amount_in_million_krw": 4641
            },
            {
              "quarter": "2024 2Q",
              "sales_amount_in_million_krw": 4840
            }
          ]
        },
        {
          "category_name": "Body Care",
          "main_brands": [
            "더마비"
          ],
          "q2_2024_sales_amount": "48억",
          "q2_2024_sales_percentage": "16%",
          "yoy_growth": "38% 성장",
          "quarterly_sales_trend": [
            {
              "quarter": "2023 2Q",
              "sales_amount_in_million_krw": 3645
            },
            {
              "quarter": "2023 3Q",
              "sales_amount_in_million_krw": 3252
            },
            {
              "quarter": "2023 4Q",
              "sales_amount_in_million_krw": 3901
            },
            {
              "quarter": "2024 1Q",
              "sales_amount_in_million_krw": 3968
            },
            {
              "quarter": "2024 2Q",
              "sales_amount_in_million_krw": 3352
            }
          ]
        },
        {
          "category_name": "Others",
          "main_brands": [
            "OEM",
            "기타 브랜드"
          ],
          "q2_2024_sales_amount": "51억",
          "q2_2024_sales_percentage": "17%",
          "yoy_growth": "467% 성장",
          "quarterly_sales_trend": [
            {
              "quarter": "2023 2Q",
              "sales_amount_in_million_krw": 8354
            },
            {
              "quarter": "2023 3Q",
              "sales_amount_in_million_krw": 5228
            },
            {
              "quarter": "2023 4Q",
              "sales_amount_in_million_krw": 5068
            },
            {
              "quarter": "2024 1Q",
              "sales_amount_in_million_krw": 4220
            },
            {
              "quarter": "2024 2Q",
              "sales_amount_in_million_krw": 4048
            }
          ]
        }
      ]
    }
  },
  {
    "5": {
      "company_info": {
        "name": "NEOPHARM",
        "slogan": {
          "english": "The Global Leader In Skin Science",
          "korean": "피부 과학의 선도기업"
        },
        "description": "네오팜은 피부과학의 선도기업으로서, 끊임없는 기술혁신으로 인류공헌에 앞장섭니다."
      },
      "document_sections": [
        {
          "title": "Appendix"
        },
        {
          "title": "1. 재무 사항"
        }
      ],
      "products": [
        {
          "brand": "Realbarrier",
          "product_name": {
            "english": "EXTREME CREAM",
            "korean": "익스트림 크림"
          },
          "variant": "Light",
          "volume_text": "70ml/2.36fl.oz.",
          "volume_ml": 70.0,
          "volume_floz": 2.36
        },
        {
          "brand": "Realbarrier",
          "product_name": {
            "english": "EXTREME CREAM",
            "korean": "익스트림 크림"
          },
          "variant": "Light",
          "volume_text": "65ml/2.19fl.oz.",
          "volume_ml": 65.0,
          "volume_floz": 2.19
        },
        {
          "brand": "Realbarrier",
          "product_name": {
            "english": "EXTREME CREAM",
            "korean": "익스트림 크림"
          },
          "variant": "Original",
          "volume_text": "70ml/2.36fl.oz.",
          "volume_ml": 70.0,
          "volume_floz": 2.36
        },
        {
          "brand": "Realbarrier",
          "product_name": {
            "english": "AQUA SOOTHING AMPOULE MASK",
            "korean": "아쿠아 수딩 앰플 마스크"
          },
          "variant": null,
          "volume_text": "28ml/0.94fl.oz.",
          "volume_ml": 28.0,
          "volume_floz": 0.94
        },
        {
          "brand": "Realbarrier",
          "product_name": {
            "english": "AQUA SOOTHING TONER",
            "korean": "아쿠아 수딩 토너"
          },
          "variant": null,
          "volume_text": null,
          "volume_ml": null,
          "volume_floz": null
        },
        {
          "brand": "Realbarrier",
          "product_name": {
            "english": "AQUA SOOTHING CREAM",
            "korean": "아쿠아 수딩 크림"
          },
          "variant": null,
          "volume_text": null,
          "volume_ml": null,
          "volume_floz": null
        }
      ]
    }
  },
  {
    "6": {
      "company_name": "NEOPHARM",
      "unit": "억원",
      "summary_financial_statements": [
        {
          "year": 2020,
          "current_assets": 1136,
          "non_current_assets": 194,
          "total_assets": 1330,
          "current_liabilities": 149,
          "non_current_liabilities": 4,
          "total_liabilities": 153,
          "capital_stock": 41,
          "capital_surplus": 451,
          "capital_adjustments": -26,
          "accumulated_other_comprehensive_income": 0,
          "retained_earnings": 711,
          "total_equity": 1177
        },
        {
          "year": 2021,
          "current_assets": 1215,
          "non_current_assets": 219,
          "total_assets": 1434,
          "current_liabilities": 129,
          "non_current_liabilities": 2,
          "total_liabilities": 131,
          "capital_stock": 41,
          "capital_surplus": 457,
          "capital_adjustments": -32,
          "accumulated_other_comprehensive_income": -1,
          "retained_earnings": 838,
          "total_equity": 1303
        },
        {
          "year": 2022,
          "current_assets": 1313,
          "non_current_assets": 241,
          "total_assets": 1553,
          "current_liabilities": 131,
          "non_current_liabilities": 0,
          "total_liabilities": 131,
          "capital_stock": 41,
          "capital_surplus": 457,
          "capital_adjustments": -32,
          "accumulated_other_comprehensive_income": -5,
          "retained_earnings": 961,
          "total_equity": 1422
        },
        {
          "year": 2023,
          "current_assets": 1345,
          "non_current_assets": 430,
          "total_assets": 1775,
          "current_liabilities": 169,
          "non_current_liabilities": 5,
          "total_liabilities": 174,
          "capital_stock": 41,
          "capital_surplus": 457,
          "capital_adjustments": -32,
          "accumulated_other_comprehensive_income": -2,
          "retained_earnings": 1136,
          "total_equity": 1600
        }
      ],
      "summary_income_statement": [
        {
          "year": 2020,
          "revenue": 816,
          "cost_of_revenue": 230,
          "gross_profit": 586,
          "gross_profit_margin": "72%",
          "selling_general_administrative_expenses": 367,
          "operating_income": 219,
          "operating_income_margin": "27%",
          "non_operating_income": 17,
          "non_operating_expenses": 6,
          "income_before_tax": 229,
          "income_tax_expense": 48,
          "net_income": 181,
          "net_income_margin": "22%"
        },
        {
          "year": 2021,
          "revenue": 879,
          "cost_of_revenue": 255,
          "gross_profit": 624,
          "gross_profit_margin": "71%",
          "selling_general_administrative_expenses": 400,
          "operating_income": 224,
          "operating_income_margin": "26%",
          "non_operating_income": 20,
          "non_operating_expenses": 6,
          "income_before_tax": 238,
          "income_tax_expense": 61,
          "net_income": 177,
          "net_income_margin": "20%"
        },
        {
          "year": 2022,
          "revenue": 850,
          "cost_of_revenue": 267,
          "gross_profit": 584,
          "gross_profit_margin": "69%",
          "selling_general_administrative_expenses": 369,
          "operating_income": 214,
          "operating_income_margin": "25%",
          "non_operating_income": 25,
          "non_operating_expenses": 6,
          "income_before_tax": 233,
          "income_tax_expense": 63,
          "net_income": 170,
          "net_income_margin": "20%"
        },
        {
          "year": 2023,
          "revenue": 971,
          "cost_of_revenue": 317,
          "gross_profit": 654,
          "gross_profit_margin": "67%",
          "selling_general_administrative_expenses": 401,
          "operating_income": 253,
          "operating_income_margin": "26%",
          "non_operating_income": 49,
          "non_operating_expenses": 8,
          "income_before_tax": 294,
          "income_tax_expense": 62,
          "net_income": 232,
          "net_income_margin": "24%"
        }
      ],
      "note": "K-IFRS 연결기준"
    }
  },
  {
    "7": {
      "company_name": "주식회사 네오팜",
      "address": "대전광역시 유성구 테크노로 309-8",
      "tel": "042-864-0043",
      "fax": "042-864-0039",
      "website": "www.neopharm.co.kr"
    }
  }
]